BIG PHARMA WATCH: DRUG COMPANY VERTEX PRICE-GOUGING BRAND NAME CYSTIC FIBROSIS TREATMENTS AND BANKING HUGE PROFITS

Patient Advocates Warn Access to Egregiously Priced Treatments at Risk Drug company Vertex manufacturers four key cystic fibrosis (CF) treatments, Trikafta, Symdeko, Orkambi

11-30-2022 Read More

CSRXP: NEW MOST EXPENSIVE DRUG IN THE WORLD CARRIES PRICE TAG $600,000 HIGHER THAN ESTIMATES FOR A FAIR PRICE

Hemgenix Pricing Reflects Escalating Big Pharma Trend of Setting Higher and More Out-of-Control Launch Prices on New Products For Immediate Release Contact: Jon Conradi 860-235-3884

11-30-2022 Read More

CSRXP: OUTRAGEOUS PRICE TAG ON NEW DIABETES DRUG LATEST EXAMPLE OF BIG PHARMA’S OUT-OF-CONTROL LAUNCH PRICES

Drug Company Sets Nearly $200,000 Price on Newly Approved Treatment for Type 1 Diabetes, Blowing Past Wall Street Expectations For Immediate Release Contact: Jon Conradi 860-235-3884

11-21-2022 Read More

CSRXP APPLAUDS FDA APPROVAL OF SECOND INTERCHANGEABLE BIOSIMILAR FOR INSULIN

Interchangeable Biosimilars Help Provide Patients with Greater Choice and More Affordable Alternatives to High-Priced Brand Name Drugs For Immediate Release Contact: Jon Conradi 860-235-3884

11-18-2022 Read More

TWO BIRDS OF A FEATHER: BIG PHARMA COMPANIES EYE MERGER TO UNDERMINE GENERIC COMPETITION TO OPIOID TREATMENTS

Brand Name Drug Company to Acquire Manufacturer of Narcan as Both Work to Block Competition from More Affordable Alternatives In case you missed it, on Monday pharmaceutical company Indivior

11-16-2022 Read More

BIG PHARMA EARNINGS WATCH: GLAXOSMITHKLINE, AMGEN, ASTRAZENECA

Big Pharma Giants Notch Expectation-Busting Earnings After Continuing to Hike Drug Prices A final round of Big Pharma third quarter earnings reports from GlaxoSmithKline

11-11-2022 Read More

BIG PHARMA EARNINGS WATCH: PFIZER, ABBVIE, SANOFI, ELI LILLY

Big Pharma Giants Beat Wall Street Expectations After Year of Price Increases, Pfizer’s Bourla Pressed on “Sheer Magnitude” of COVID-19 Vaccine Price Hike on Earnings Call Big Pharma companies

11-4-2022 Read More

BIG PHARMA WATCH: REPRESENTATIVE KATIE PORTER HIGHLIGHTS BIG PHARMA’S OUTRAGEOUS CANCER DRUG LAUNCH PRICES

New Report Finds Brand Name Drug Companies Increased Prices on New Oncology Treatments by 25 Percent Over Four Years This week, U.S. Representative Katie Porter (D-CA) released a report,

11-3-2022 Read More

DOSE OF REALITY: NEW STUDY UNDERSCORES BIG PHARMA’S PRICING PRACTICES ARE ABOUT PROFITS, NOT VALUE FOR PATIENTS

JAMA Analysis Finds No Correlation Between Cancer Drug Prices and Effectiveness A new study published in the Journal of the American Medical Association (JAMA) Internal Medicine found a lack of

11-1-2022 Read More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.